Information  X 
Enter a valid email address

Balfour Beatty PLC (BBY)

  Print          Annual reports

Tuesday 15 June, 2021

Balfour Beatty PLC

Director Declaration

RNS Number : 9206B
Balfour Beatty PLC
15 June 2021




15 June 2021

In accordance with Listing Rule 9.6.14R (2), Balfour Beatty plc ("Balfour Beatty"), the international infrastructure group, announces that Barbara Moorhouse, Independent Non-Executive Director of Balfour Beatty, will be appointed as the Senior Independent Non-Executive Director and Chair of the Audit Committee of Medica Group Plc with effect from 1 July 2021.



Analyst/investor enquiries:

Angus Barry
Tel. +44 (0)7966 281 635
[email protected]  


Media enquiries: 

Antonia Walton
Tel. +44 (0) 7966 929 633
[email protected]


Notes to editors:

· Balfour Beatty is a leading international infrastructure group with 26,000 employees driving the delivery of powerful new solutions, shaping thinking, creating skylines and inspiring a new generation of talent to be the change-makers of tomorrow. 

· We finance, develop, build, maintain and operate the increasingly complex and critical infrastructure that supports national economies and deliver projects at the heart of local communities.

· Over the last 112 years we have created iconic buildings and infrastructure all over the world including: the £1.5 billion A14 improvement scheme - Britain's biggest road project; Hong Kong's HK$5.5 billion world-class harbour theatre project for the West Kowloon Cultural District Authority; and the 12.5 mile $429 million North Metro Commuter Rail line in Colorado, US.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

a d v e r t i s e m e n t